Prognostic re-evaluation of peritoneal lavage cytology in Japanese patients with gastric carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 261-265

  Yamamoto, Manabu ^a   Matsuyama, Ayumi ^a   Kameyama, Toshifumi ^a   Okamoto, Masahiro ^a   Okazaki, Jin ^a   Utsunomiya, Tohru ^a   Tsutsui, Shinichi ^a   Fujiwara, Megumu ^a   Ishida, Teruyoshi ^a  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Cytology; Gastric carcinoma; Peritoneal washing

Indexed keywords

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; JAPANESE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; SURVIVAL RATE;

CARCINOMA; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; JAPAN; MALE; MIDDLE AGED; PERITONEAL LAVAGE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 64949201877     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K: Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000; 87:353-357.
2. Moore GE, Sako K, Kondo T, Badillo J, Burke E: Assessment of the exfoliation of tumor cells into the body cavities. Surg Gynecol Obestet 1961; 112:469-474.
3. Creasman WT, Rutledge F: The prognostic value of peritoneal cytology in gynecological malignant disease. Am J Obestet Gynecol 1971; 110:773-781.
4. Miyashiro I, Takachi K, Doki Y, et al: When is curative gastrectomy justified for gastric cancer with postive peritoneal lavage cytology but negative macroscopic peritoneal implant? World J Surg 2005; 29:1131-1134.
5. Yamamoto M, Baba H, Kakeji Y, et al: Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology 2004; 67:19-26.
6. TNM classification of malignant tumors (UICC). 5th edition, New York, WILEY.LISS, 1997.
7. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. The 12th Edition. Tokyo: Kanehara; 1993.
8. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. The 13th Edition. Tokyo: Kanehara; 1999.
9. Bando E, Yonemura Y, Takeshita Y, et al: Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg 1999;178:256-262.
10. Boku T, Nakane Y, Minoura T, et al: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77:436-439.
11. De La Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A: Fibronectin interaction with alpha 4 beta 1 integrine prevents apoptosis in B cell chronic lympo-cytic leukemia: correlation with Bcl-2 and Bax. Leukemia 1999; 13:266-274.
12. Sakuramoto S, Sasako M, Yamaguchi T, et al: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357:1810-2180.
13. Oshima T, Yamada R, Hatori S, Kunisaki C, Imada T: Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer. Oncology Rep 2006; 16:361-366.
14. Osugi H, Takada N, Takemura M, et al: Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination. Oncology Rep 2002; 9:811-818.
15. Bunt A, Hermans J, Boon MC, et al: Evaluation of the extent of lymphadenectomy in a randomized trial of Western-versus Japanese-type surgery in gastric cancer. J Clin Oncol 1994;12:417-422.
16. Yamamoto M, Taguchi K, Baba H, et al: Peritoneal dissemination of early gastric cancer: report of a case. Surg Today 2006; 36:835-838.
17. Yamamoto M, Baba H, Toh Y, Okamura T, Maehara Y: Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 2007; 133:471-476.
18. Yonemura Y, Nojima N, Kawamura T, et al: Mechanism of the formation of peritoneal dissemination. In: Yonemura Y, editor. Peritoneal dissemination. Molecular mechanisms and the latest therapy. Kanazawa: Maeda Shoten; 1998, p. 1-46.
19. Sampson JA: Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol 1931; 7:423-443.
20. Hagiwara A, Takahashi T, Sawai K, et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 1993; 54:687-692.
21. de Mazoni G, Verlato G, Di Leo A, et al: Peritoneal cytology dose not increase the prognostic information provided by TMN in gastric cancer. World J Surg 2006; 30:579-584.